PhytoHealth
懷特生技新藥股份有限公司
PhytoHealth is a Taiwan TWSE-listed biotechnology company; its most advanced asset is PG2 (TFDA marketing authorization obtained; marketed, Cancer-related fatigue), as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| PG2 | — | TFDA marketing authorization obtained; marketed | Cancer-related fatigue | Taiwan | — | Company disclosure |
| PHN031 | — | — | — | — | — | Company disclosure |
| PHN033 | — | — | — | — | — | Company disclosure |
Key events
No verified events in the past twelve months.
Related Drugnews articles
No related articles in this language.